Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jove

Showing results (511-520 of 517) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 517 results.
Cancer Cell|December 8, 2009
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumorsMichael Hedvat, Dennis Huszar, Andreas Herrmann, et al.
British Journal of Cancer|March 13, 2020
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumoursJohann de Bono, Chia-Chi Lin, Li-Tzong Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumorsE Pros, M Saigi, D Alameda, et al.
Science Translational Medicine|October 15, 2020
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumorsIván Márquez-Rodas, Federico Longo, Maria E Rodriguez-Ruiz, et al.
Intensive Care Medicine|February 22, 2017
A multifaceted educational intervention shortened time to antibiotic administration in children with severe sepsis and septic shock: ABISS Edusepsis pediatric studyElisabeth Esteban, Sylvia Belda, Patricia García-Soler, et al.
New Microbes and New Infections|November 11, 2025
Clinical features of yellow fever in cases from Bolivia, Ecuador, Colombia, and Peru (2023-2025): A descriptive retrospective studyAlfonso J Rodriguez-Morales, Boris Chang-Cheng, Rosmery Gross, et al.
Obesity Surgery|February 10, 2022
Higher Adherence to ERAS Society® Recommendations is Associated with Shorter Hospital Stay Without an Increase in Postoperative Complications or Readmissions in Bariatric Surgery: the Association Between Use of Enhanced Recovery After Surgery Protocols and Postoperative Complications after Bariatric Surgery (POWER 3) Multicenter Observational StudyJavier Ripollés-Melchor, Raquel Sánchez-Santos, Ane Abad-Motos, et al.
Pageof 52

Showing results (511-520 of 517) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 517 results.
Cancer Cell|December 8, 2009
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumorsMichael Hedvat, Dennis Huszar, Andreas Herrmann, et al.
British Journal of Cancer|March 13, 2020
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumoursJohann de Bono, Chia-Chi Lin, Li-Tzong Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumorsE Pros, M Saigi, D Alameda, et al.
Science Translational Medicine|October 15, 2020
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumorsIván Márquez-Rodas, Federico Longo, Maria E Rodriguez-Ruiz, et al.
Intensive Care Medicine|February 22, 2017
A multifaceted educational intervention shortened time to antibiotic administration in children with severe sepsis and septic shock: ABISS Edusepsis pediatric studyElisabeth Esteban, Sylvia Belda, Patricia García-Soler, et al.
New Microbes and New Infections|November 11, 2025
Clinical features of yellow fever in cases from Bolivia, Ecuador, Colombia, and Peru (2023-2025): A descriptive retrospective studyAlfonso J Rodriguez-Morales, Boris Chang-Cheng, Rosmery Gross, et al.
Obesity Surgery|February 10, 2022
Higher Adherence to ERAS Society® Recommendations is Associated with Shorter Hospital Stay Without an Increase in Postoperative Complications or Readmissions in Bariatric Surgery: the Association Between Use of Enhanced Recovery After Surgery Protocols and Postoperative Complications after Bariatric Surgery (POWER 3) Multicenter Observational StudyJavier Ripollés-Melchor, Raquel Sánchez-Santos, Ane Abad-Motos, et al.
Pageof 52